Dr. Nikolaos Sismanopoulos, MD

Dr. Sismanopoulos practices at Rhode Island Hospital/Hasbro Children's in Providence, Rhode Island.

Dr. Sismanopoulos' NPI, 1225393432, was assigned on July 13, 2012. Dr. Sismanopoulos holds Rhode Island license MD16384.

Dr. Sismanopoulos' primary practice is Rhode Island Hospital/Hasbro Children's, at 593 Eddy St, Providence, RI 02903 in Providence County. The practice phone is (401) 444-6966.

Dr. Sismanopoulos' primary practice is Rhode Island Hospital/Hasbro Children's in Providence, Rhode Island. Dr. Sismanopoulos is also affiliated with The Miriam Hospital. The medical group on file is Brown Health Medical Group. Dmand AI also links Dr. Sismanopoulos to 1 more hospital, 1 hospice and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sismanopoulos practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Sismanopoulos' primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Sismanopoulos is licensed in Rhode Island.

CMS data shows 313 Medicare services from Dr. Sismanopoulos across 4 procedure codes in 2024, for 118 Medicare patients. Medicare paid $24,448 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 118 Medicare patients who saw Dr. Sismanopoulos in 2024. The largest group is 75 to 84, with 43 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 34% are also on Medicaid. Their average risk score is 2.87, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sismanopoulos' median patient age at 74, with 46% women.

In 2024, Dr. Sismanopoulos wrote 286 Medicare Part D claims for 102 patients. 82% of them were for generic drugs. CMS names the drug for 63 of them, across 4 drugs with 11 or more claims each, at $441 in total drug cost. In 2023, CMS named 12 claims across 1 drug.

Dr. Sismanopoulos accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 14 papers to Dr. Sismanopoulos, published from 2010 to 2013. 2012 was the busiest year, with 7. The most frequent topics are Mast Cells, Inflammation and Cell Degranulation. Dr. Sismanopoulos has published most often in PLoS One. Dr. Sismanopoulos' most frequent co-authors are Asimenia Angelidou, MD, PhD, Alexandra Miniati, MD and Michail Alevizos, MD.

CMS Open Payments shows 6 general payments to Dr. Sismanopoulos from 3 drug and device companies from 2016 to 2018. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $90.